Cardiac hypertrophy is a chronic process and therefore may require high concentrations and constant exposure to the peptide Ang-(1-9) to counteract pro-growth signals, so a conventional treatment with Ang-(1-9) is impractical due to its short half-life, as it is constantly degraded by ACE. Here, ACE is linked to cardiac hypertrophy.